Macu-Guard

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

d-alpha-tocopheryl acid succinate, Quantity: 165.3 mg (Equivalent: d-alpha-tocopherol, Qty 200 IU); ascorbic acid, Quantity: 250 mg; Vaccinium myrtillus, Quantity: 100 mg (Equivalent: Vaccinium myrtillus, Qty 10 g; Equivalent: anthocyanosides (of Vaccinium myrtillus), Qty 25 mg); copper gluconate, Quantity: 7.14 mg (Equivalent: copper, Qty 1 mg); Tagetes erecta, Quantity: 133.3 mg (Equivalent: Tagetes erecta, Qty 933 mg; Equivalent: Lutein esters calculated as lutein (of Tagetes erecta), Qty 10 mg); zinc citrate dihydrate, Quantity: 77.9 mg (Equivalent: zinc, Qty 25 mg); zeaxanthin, Quantity: 2 mg

Commercializzato da:

Herbs of Gold Pty Ltd

INN (Nome Internazionale):

Ascorbic acid,Copper gluconate,d-alpha-Tocopheryl acid succinate,Tagetes erecta,Vaccinium myrtillus,zinc citrate dihydrate,Zeaxa

Forma farmaceutica:

Tablet, film coated

Composizione:

Excipient Ingredients: calcium hydrogen phosphate dihydrate; crospovidone; magnesium stearate; microcrystalline cellulose; Carnauba Wax; maltodextrin; macrogol 400; colloidal anhydrous silica; iron oxide red; hypromellose; ethylcellulose

Via di somministrazione:

Oral

Indicazioni terapeutiche:

Antioxidant/Reduce free radicals formed in the body ; Maintain/support healthy eye function ; Maintain/support eye health ; Helps maintain/support eye macula health ; Helps maintain/support eye retina health ; Helps temporarily relieve light sensitivity ; Aids/assists eye adaption to variations in light intensity/night vision ; Maintain/support healthy eyesight/vision

Dettagli prodotto:

Visual Identification: ;

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2016-11-30